Webcast - ASCO Direct™ Highlights: 2021 Official Annual Meeting Review

This accredited continuing education activity “Webcast - ASCO Direct™ Highlights: 2021 Official Annual Meeting Review", is recorded from the live oncology conference held on 7/24/2021 - 7/25/2021. 

If you participated in the live conference titled - ASCO Direct™ Highlights: 2021 Official Annual Meeting Review on 7/24/2021-7/25/2021 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that webinar on 7/24/2021-7/25/2021.  However, you may enroll in this activity to review the contents. 


REGISTRATION FEES:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

Healthcare providers ($0.00)

Industry employees - $250 - all industry employees must pay a registration fee even if you are a licensed HCP.

If you are a healthcare provider involved in patient care and you are not employed by the Industry, then you don't pay anything to register for this activity.

If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $1030 per participant.

If you paid to join the live meeting associated with this webcast and wish to register for this enduring material please contact us and we will register you for free.

Target Audience

  • Oncologists
  • Oncology Nurse Practitioners & Physician Assistants 
  • Oncology Pharmacists
  • Oncology Nurses
  • Oncology Residents/Fellow
  • Oncology Researchers

Learning Objectives

At the conclusion of the activity, participants will be able to:

  • Discuss new and updated treatment options for patients with hematologic malignancies and solid tumors
  • Identify side effects, indications, and contra-indications of therapies used to diagnose and treat cancers
  • Explain how to effectively manage side-effects associated with cancer treatment
  • Review abstracts presented at ASCO® 2021 and discuss their application in clinical settings
Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
Course opens: 
08/21/2021
Course expires: 
07/14/2022
Cost:
$50.00

 

This educational activity features recorded videos from the live webinar titled - ASCO Direct Highlights: 2021 Official Annual Meeting Review held July 24-25,2021.

The videos are placed in the following order. Feel free to view the content that is relevant to you.

Participants should claim continuing education credits to the extent of their participation.


 

Lymphoid malignancies: 

  • Updates in lymphoma – 30 minutes - Dr. Ranjana Advani

  • Updates in CLL – 30 minutes - Dr. P Venugopal

  • Rapid fire Q&A – 15 minutes - Dr. David Aboulafia 

Hematologic malignancies: 

  • Management of multiple myeloma – 30 minutes - Dr. Shaji Kumar

  • Acute leukemia – new updates – 30 minutes - Dr. Elihu Estey

  • Rapid fire Q&A – 15 minutes - Dr. Andrew Cowan

 Lung cancer:

  • Recent updates in NSCLC – 30 minutes - Dr. Jack West

  • Small cell lung cancer  - 30 minutes - Dr. Rafael Santana-Davila

  • Rapid fire Q&A – 15 minutes - Dr. Joe Rosales

Women’s cancer 

  • Non-metastatic breast cancer – 30 minutes - Dr. Siddhartha Yadav

  • Metastatic breast cancer - 30 minutes - Dr. Mark Pegram

  • Gynecologic malignancies – 30 minutes - Dr. Kalyan Banda

  • Q & A – 15 minutes

General Oncology session

  • Sarcoma updates – 30 minutes - Dr. Michael Wagner

 

Shaji Kumar, MD

Professor of Medicine

Mayo Clinic

Learn More

image

Program Chair

Shailender Bhatia, MD

Associate Professor 

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

image 

David Aboulafia, MD

Medical Oncologist/Hematologist

Virginia Mason

Learn More

image

Mark Pegram, MD

Professor of Medicine

Stanford University

Learn More

image

Siddhartha Yadav, MD

Medical Oncologist

Mayo Clinic

Learn More

Sakti Chakrabarti, MD

Associate Professor of Medicine

Medical College of Wisconsin

Learn More

image

Jack West, MD

Medical Oncologist

City of Hope

Learn More

Placeholder

Parameswaran Venugopal, MD

Professor of Medicine & Director - Section of Hematology

Rush University

Learn More

Ranjana Advani, MD

Medical Oncologist

Stanford University

Learn More

 

 

Andrew Cowan, MD

Assistant Professor of Medicine

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance

Learn More

Cristina Rodriguez, MD

Associate Professor of Medicine

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance

Learn More

Fengting Yan, MD

Medical Oncologist

Swedish Medical Center

Learn More

Andrew Coveler, MD

Associate Professor of Medicine

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance

Learn More

Neeraj Agarwal, MD

Professor of Medicine

University of Utah, Huntsman Cancer Institute

Learn More

Rafael Santana-Davila, MD

Associate Professor of Medicine 

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

Michael Wagner, MD

Assistant Professor of Medicine

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

Kalyan Banda, MD

Assistant Professor of Medicine 

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

Vyshak Venur, MD

Assistant Professor of Medicine 

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

Cristina Merkhofer, MD

Assistant Professor of Medicine 

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

Stacey Cohen, MD

Associate Professor of Medicine 

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

Jacob Appelbaum, MD, PhD

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

Scott Tykodi, MD

Associate Professor of Medicine 

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

Christina Poh, MD

Assistant Professor of Medicine 

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

Glynn Gilcrease III, MD

Assistant Professor of Medicine

University of Utah, Huntsman Cancer Institute

Learn More

Joseph Rosales, MD

Medical Oncologist/Hematologist

Virginia Mason

Learn More

Lindsay Hannan, MD

Clinical Assistant Professor of Medicine 

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

  

 

Disclosures: 

No Members of this activity's planning committee or faculty have any relevant financial relationship with an ineligible entity except for the following faculties. All conflicts have been mitigated. 

Shaji Kumar, MD

Research support/Grant: Abbvie, Amgen, BMS, Carsgen, Janssen,  KITE, Merck,  Astra-Zeneca, Novartis, Roche-Genentech,  Takeda, Tenebio

Consulting/Advisory Board participation: (with no personal payments) Abbvie, Amgen, BMS, Janssen,  Roche-Genentech, Takeda, KITE, Astra-Zeneca, Bluebird Bio, and (with personal payment) Oncopeptides, Beigene, Antengene

 

Shailender Bhatia, MD

Research support/Grant to institution: EMD Serono, Merck, BMS, NantKwest, Novartis, Nektar, Exicure, Checkmate Pharma, Xencor

Consultant (advisory board with honoraria): BMS, Sanofi-Regeneron, EMD-Serono, Genentech

 

Mark Pegram, MD

Consultant: Pfizer, Eli Lilly, Novartis, Genentech/Roche, AstraZeneca

 

Sakti Chakrabarti, MD

Consultant - HalioDx, QED Therapeutics, DAVA Oncology,

Grant/Research Support - MERCK, Taiho Pharmaceutical, Roche Tissue

Diagnostics, Natera Inc..

 

Howard Jack West, MD

Consultant: Amgen, AstraZeneca, Genentech/Roche, Merck, Mirati, Regeneron

Speaker Bureau: Merck, AstraZeneca

 

Andrew Cowan, MD

Research support/Grant: Janssen, Bristol Myers Squibb, Abbvie, Sanofi Aventis, Harpoon

Consultant: Janssen, Abbvie, Cellectra, Sanofi, GSK

 

Cristina Rodriguez, MD

Research support/Grant: AstraZeneca​​, Ayala​​, Bristol Myers Squibb, Cue Biopharma​, Kura​, Merck​​

Consultant: Cue Biopharma​

 

Andrew Coveler, MD

Research support/Grant: Actuate, Amgen, Medimmune

Consultant: Novocure, Seagen, Surface

 

Neeraj Agarwal, MD

Consultant: Astellas, AstraZeneca, Aveo, Bayer, BMS, Calithera, Clovis, Eisai, Eli Lilly, EMD Serono, Exelixis, Foundation Medicine, Genenetech, Janssen, Merck, MEI Pharma, Nektar, Novartis, Pfizer, Pharmacyclics, Seattle Genetics

 

Rafael Santna-Davila, MD

Consultant: Genentech, Bayer, NGM Biopharmaceuticals, Takeda, Lilly, AstraZeneca, Culinan Oncology, BMS

Research Support to Institution: Bayer, AstraZeneca, Genentech, Lilly, BeyondSPring Pharmaceuticals, ISA Pharmaceuticals, Abbvie

 

Michael Wagner, MD

Consultant: Adaptimmune, Deciphera

Research support/Grant: Adaptimmune, Deciphera, Athenex, GSK, Inhibrx, Incyte

 

Vyshak Alva Venur, MD

Consultant: Seagen

 

Stacy Cohen, MD

Consultant: Natera

 

Scott Tykodi, MD

Consultant: Exelixis, Merck, BMS, Intellisphere

Research Support/Grant: BMS, Genentech, Pfizer, Nektar Therapeutics, Merck, Exelixis, Jounce Therapeutics

 

Ranjana Advani, MD

Commercial Interest(s): Agensys, Relationship: Research support/Grant

Commercial Interest(s): Celgene, Relationship: Research support/Grant

Commercial Interest(s): Genentech/Roche, Relationship: Research support/Grant

Consultant: iDMC

Commercial Interest(s): Forty Seven/Gilead, Relationship: Research support/Grant

Commercial Interest(s): Janssen Pharmaceuticals, Relationship: Research support/Grant

Commercial Interest(s): Kura, Relationship: Research support/Grant

Consultant

Commercial Interest(s): Merck, Relationship: Research support/Grant

Consultant

Commercial Interest(s): Millenium, Relationship: Research support/Grant

Commercial Interest(s): Pharmacyclics, Relationship: Research support/Grant

Commercial Interest(s): Regeneron, Relationship: Research support/Grant

Commercial Interest(s): Seattle Genetics, Relationship: Research support/Grant, Please list if you selected other):

Commercial Interest(s): Cytier Therapeutics, Relationship: Research support/Grant

Commercial Interest(s): Incyte, Relationship: Consultant

Commercial Interest(s): Gilead, Relationship: Consultant

Commercial Interest(s): Bristol Myers Squibb/Celgene, Relationship: Consultant

Commercial Interest(s): BeiGene Ltd, Relationship: Consultant

Commercial Interest(s): Daiichi Sankyo, Relationship: Consultant

Commercial Interest(s): Sanofi, Relationship: Other

Commercial Interest(s): Takeda, Relationship: Other: CME

Commercial Interest(s): Karyopharm, Relationship: Consultant

Commercial Interest(s): ADC Therapeutics, Relationship: Consultant

Important Information about Claiming CME for this activity:

If you participated in the live webinar titled - ASCO Direct™ Highlights: 2021 Official Annual Meeting Review on 7/24/2021-7/25/2021 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that webinar on 7/24/2021-7/52/2021. However, you can still enroll in this activity and review the contents as needed.

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

The Binaytara Foundation designates this enduring activity for a maximum of -  6 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to - 6 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6 Contact Hours.

ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to -  Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Available Credit

  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.

Price

Cost:
$50.00
Please login or register to take this course.

REGISTRATION FEES:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

Healthcare providers ($0.00)

Industry employees ($500 + 3% Credit card fee) 

If you are a healthcare provider involved in patient care and you are not employed by the Industry, register for free!

If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $1030 per participant.

If you paid to join the live meeting and wish to register for this enduring material please contact us and we will register you for free.

Cancellation Policy

You may cancel your enrollment at any time. No credits will be offered if you do not complete all required steps of this activity which include registration, watching the recorded content, and completion of pre & post tests as well as course evaluations.

Refund Policy 

This activity is free for all healthcare providers who are not employees of an ineligible entity.

No refunds will be issued if you have started watching the recorded content.